search

Journal of the Royal Statistical Society Series C: Applied Statistics, Volume 73, Issue 2, March 2024, Pages 478–496, https://doi.org/10.1093/jrsssc/qlad105

Published: 08 January 2024

Supplementary data

Journal Article

Social determinants of cognitive outcomes in survivors of pediatric brain tumors treated with conformal radiation therapy

PDF

Taylor N Mule' and others

in Neuro-Oncology

Neuro-Oncology, Volume 25, Issue 10, October 2023, Pages 1842–1851, https://doi.org/10.1093/neuonc/noad080

Published: 26 April 2023

Supplementary data

Journal Article

A High-Dimensional Mediation Model for a Neuroimaging Mediator: Integrating Clinical, Neuroimaging, and Neurocognitive Data to Mitigate Late Effects in Pediatric Cancer

PDF

Jade Xiaoqing Wang and others

in Biometrics

Biometrics, Volume 79, Issue 3, September 2023, Pages 2430–2443, https://doi.org/10.1111/biom.13729

Published: 12 August 2022

Supplementary data

Journal Article

QOL-13. Impact of hearing loss on neuropsychological functioning in children treated for medulloblastoma: A report from the Children’s Oncology Group (COG)

PDF

Leanne Embry and others

in Neuro-Oncology

Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i136, https://doi.org/10.1093/neuonc/noac079.496

Published: 03 June 2022

Journal Article

MEDB-69. Clinical and molecular meta-analysis of three major medulloblastoma clinical trials (ACNS0331, SJMB03, ACNS0332) uncovers novel strategies to improve risk-stratified therapy

PDF

Kyle S Smith and others

in Neuro-Oncology

Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i122, https://doi.org/10.1093/neuonc/noac079.443

Published: 03 June 2022

2 3 4

Modify your search

Availability

NARROW

Format

Subject

Type

Journal

Publication date

The G-protein β subunit SlGB1 regulates tyramine-derived phenolamide metabolism for shoot apex growth and development in tomato Get access

Isotretinoin has no effect on event-free survival across high-risk medulloblastoma molecular groups when added to maintenance: A secondary analysis of the Children's Oncology Group ACNS0332 data

MRI identifies disrupted cerebral development in medulloblastoma patients

6471 Adult Height in Male Survivors of Childhood Cancer Treated with Aromatase Inhibitors and Growth Hormone

MDB-86. ISOTRETINOIN HAS NO EFFECT ON EVENT FREE SURVIVAL ACROSS HIGH-RISK MEDULLOBLASTOMA MOLECULAR SUBGROUPS WHEN ADDED TO MAINTENANCE CHEMOTHERAPY: A SECONDARY ANALYSIS OF THE CHILDREN’S ONCOLOGY GROUP ACNS0332 DATA

IMG-01. LONGITUDINAL SIGNAL CHANGES IN THE DENTATE AND INFERIOR OLIVARY NUCLEI IN PATIENTS WITH CEREBELLAR MUTISM SYNDROME

QOL-39. FATIGUE AS A RISK FACTOR FOR REDUCED SOCIAL CONNECTEDNESS IN PEDIATRIC BRAIN TUMOR SURVIVORS

ATRT-11. IRS-III: LONG-TERM FOLLOW-UP SHOWS FAVORABLE OUTCOMES AND DURABLE RESPONSES FOR LOCALIZED ATYPICAL TERATOID RHABDOID TUMOR (ATRT)

NFS-08. CLINICAL AND MOLECULAR FEATURES OF HIGH-GRADE GLIOMA IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS TYPE 1: A PRELIMINARY ANALYSIS

NFS-18. LOWER BODY SURFACE AREA IS ASSOCIATED WITH INCREASED LIKELIHOOD OF PLEXIFORM NEUROFIBROMA RESPONSE TO MEK INHIBITION

MDB-100. RETROSPECTIVE ANALYSIS OF CUMULATIVE DOSING OF CHEMOTHERAPY AGENTS AND THE EFFECT ON SURVIVAL IN PATIENTS WITH AVERAGE RISK MEDULLOBLASTOMA TREATED ON CHILDRENS ONCOLOGY GROUP STUDY ACNS0331

IMG-14. DIAGNOSTIC UTILITY OF THE T2-FLAIR MISMATCH SIGN FOR DNETS AND ITS ASSOCIATION WITH FGFR1 ALTERATIONS

[11C]-methionine positron emission tomography in the evaluation of pediatric low-grade gliomas

Performance and symptom validity indicators among children undergoing cognitive surveillance following treatment for craniopharyngioma

Phytosulfokine promotes fruit ripening and quality via phosphorylation of transcription factor DREB2F in tomato

Comparison of paired ordinal data with mis-classification and covariates adjustment

Social determinants of cognitive outcomes in survivors of pediatric brain tumors treated with conformal radiation therapy

A High-Dimensional Mediation Model for a Neuroimaging Mediator: Integrating Clinical, Neuroimaging, and Neurocognitive Data to Mitigate Late Effects in Pediatric Cancer

QOL-13. Impact of hearing loss on neuropsychological functioning in children treated for medulloblastoma: A report from the Children’s Oncology Group (COG)

MEDB-69. Clinical and molecular meta-analysis of three major medulloblastoma clinical trials (ACNS0331, SJMB03, ACNS0332) uncovers novel strategies to improve risk-stratified therapy

Modify your search

Publication date

This Feature Is Available To Subscribers Only